Discover why Merck is a strong, profitable pick meeting Benjamin Graham's criteria, but stay aware of potential downside ...

Wall Street traders sent stocks lower in the run-up to the Federal Reserve decision, with concerns about high valuations ...

Wall Street traders sent stocks lower in the run-up to the Federal Reserve decision, with concerns about high valuations ...

The US, a critical market for the pharmaceutical industry, accounted for 44% of AstraZeneca’s total revenue in the second ...

A clinical trial of the drug Trontinemab will aim to delay or prevent the symptoms of Alzheimer's disease, Swiss drugmaker Roche says.

A typical U.S. homes costs 5% to 10% less this year for buyers from countries whose currencies have stayed strong against a ...

Current health news covers Roche's Alzheimer's drug research, UnitedHealth's leadership hopes, Nordic Capital's ...